Geoff Martha

Founded in 1949 by Earl Bakken (who invented the first battery-powered external cardiac pacemaker), Medtronic has grown into a sprawling medical technology conglomerate operating across cardiovascular, neuroscience, medical-surgical, and diabetes segments with products used by millions of patients worldwide. Martha's strategic challenge is revitalizing growth at a company whose size and breadth have sometimes led to organizational complexity and slower innovation cycles compared to nimble specialist competitors. He has launched the Hugo robotic-assisted surgery platform (competing with Intuitive Surgical), invested in AI-powered surgical tools, and pursued portfolio optimization — divesting the patient monitoring and respiratory intervention businesses. The GLP-1 obesity drug impact on diabetes device demand (fewer insulin pump patients if diabetes is managed through medication) is a closely watched dynamic. Martha's execution on pipeline innovation, the Hugo surgical robot launch, and revenue growth acceleration across the portfolio are the primary drivers of the stock.